28/11/2020

Tech-Wiki

Vorsprung Durch Technology

Global Microbial Fermentation Technology Industry

New York, Sept. 11, 2020 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report...

New York, Sept. 11, 2020 (GLOBE NEWSWIRE) — Reportlinker.com announces the release of the report “Global Microbial Fermentation Technology Industry” – https://www.reportlinker.com/p05961041/?utm_source=GNW
7 Trillion in the year 2020, is projected to reach a revised size of US$2.3 Trillion by 2027, growing at a CAGR of 4.5% over the analysis period 2020-2027.Medical, one of the segments analyzed in the report, is projected to grow at a 3.7% CAGR to reach US$283.1 Billion by the end of the analysis period.After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Industrial segment is readjusted to a revised 4.5% CAGR for the next 7-year period. This segment currently accounts for a 44% share of the global Microbial Fermentation Technology market.

The U.S. Accounts for Over 28.9% of Global Market Size in 2020, While China is Forecast to Grow at a 7% CAGR for the Period of 2020-2027

The Microbial Fermentation Technology market in the U.S. is estimated at US$493.9 Billion in the year 2020. The country currently accounts for a 28.95% share in the global market. China, the world second largest economy, is forecast to reach an estimated market size of US$404 Billion in the year 2027 trailing a CAGR of 7% through 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.5% and 4.1% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 2.8% CAGR while Rest of European market (as defined in the study) will reach US$404 Billion by the year 2027.

Alcohol Beverages Segment Corners a 23.1% Share in 2020

In the global Alcohol Beverages segment, USA, Canada, Japan, China and Europe will drive the 4.7% CAGR estimated for this segment. These regional markets accounting for a combined market size of US$298.1 Billion in the year 2020 will reach a projected size of US$410.9 Billion by the close of the analysis period. China will remain among the fastest growing in this cluster of regional markets. Led by countries such as Australia, India, and South Korea, the market in Asia-Pacific is forecast to reach US$311.9 Billion by the year 2027, while Latin America will expand at a 6.3% CAGR through the analysis period. We bring years of research experience to this 8th edition of our report. The 290-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others,

  • Amyris, Inc.
  • Biocon Ltd.
  • BioVectra Inc.
  • Danone UK
  • F. Hoffmann-La Roche AG
  • Koninklijke DSM NV
  • Lonza Group AG
  • Novozymes A/S
  • TerraVia Holdings, Inc.
  • United Breweries Ltd.

Read the full report: https://www.reportlinker.com/p05961041/?utm_source=GNW

I. INTRODUCTION, METHODOLOGY & REPORT SCOPE

II. EXECUTIVE SUMMARY

1. MARKET OVERVIEW
Impact of Covid-19 and a Looming Global Recession
Global Competitor Market Shares
Microbial Fermentation Technology Competitor Market Share
Scenario Worldwide (in %): 2018E

2. FOCUS ON SELECT PLAYERS

3. MARKET TRENDS & DRIVERS

4. GLOBAL MARKET PERSPECTIVE
Table 1: World Current & Future Analysis for Microbial
Fermentation Technology by Geographic Region – USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa Markets – Independent Analysis of Annual Sales in
US$ Trillion for Years 2018 through 2027

Table 2: World Historic Review for Microbial Fermentation
Technology by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Trillion
for Years 2012 through 2017

Table 3: World 15-Year Perspective for Microbial Fermentation
Technology by Geographic Region – Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa Markets for Years 2012,
2018 & 2027

Table 4: World Current & Future Analysis for Medical by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Trillion for Years
2018 through 2027

Table 5: World Historic Review for Medical by Geographic Region –
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Sales in US$ Trillion for Years 2012 through 2017

Table 6: World 15-Year Perspective for Medical by Geographic
Region – Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2018 & 2027

Table 7: World Current & Future Analysis for Industrial by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Trillion for Years
2018 through 2027

Table 8: World Historic Review for Industrial by Geographic
Region – USA, Canada, Japan, China, Europe, Asia-Pacific, Latin
America, Middle East and Africa Markets – Independent Analysis
of Annual Sales in US$ Trillion for Years 2012 through 2017

Table 9: World 15-Year Perspective for Industrial by Geographic
Region – Percentage Breakdown of Value Sales for USA, Canada,
Japan, China, Europe, Asia-Pacific, Latin America, Middle East
and Africa for Years 2012, 2018 & 2027

Table 10: World Current & Future Analysis for Alcohol Beverages
by Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Trillion for Years
2018 through 2027

Table 11: World Historic Review for Alcohol Beverages by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Trillion for Years
2012 through 2017

Table 12: World 15-Year Perspective for Alcohol Beverages by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2018 & 2027

Table 13: World Current & Future Analysis for Food and Feed
Products by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Trillion
for Years 2018 through 2027

Table 14: World Historic Review for Food and Feed Products by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Trillion for Years
2012 through 2017

Table 15: World 15-Year Perspective for Food and Feed Products
by Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2018 & 2027

Table 16: World Current & Future Analysis for Biopharmaceutical
Companies by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Trillion
for Years 2018 through 2027

Table 17: World Historic Review for Biopharmaceutical Companies
by Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Trillion for Years
2012 through 2017

Table 18: World 15-Year Perspective for Biopharmaceutical
Companies by Geographic Region – Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2018 &
2027

Table 19: World Current & Future Analysis for Food and Feed
Industry by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Trillion
for Years 2018 through 2027

Table 20: World Historic Review for Food and Feed Industry by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Trillion for Years
2012 through 2017

Table 21: World 15-Year Perspective for Food and Feed Industry
by Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2018 & 2027

Table 22: World Current & Future Analysis for Contract Research
Organizations (CROs) and Contract Manufacturing Organizations
(CMOs) by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Trillion
for Years 2018 through 2027

Table 23: World Historic Review for Contract Research
Organizations (CROs) and Contract Manufacturing Organizations
(CMOs) by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Trillion
for Years 2012 through 2017

Table 24: World 15-Year Perspective for Contract Research
Organizations (CROs) and Contract Manufacturing Organizations
(CMOs) by Geographic Region – Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2018 &
2027

Table 25: World Current & Future Analysis for Academic and
Research Institutes by Geographic Region – USA, Canada, Japan,
China, Europe, Asia-Pacific, Latin America, Middle East and
Africa Markets – Independent Analysis of Annual Sales in US$
Trillion for Years 2018 through 2027

Table 26: World Historic Review for Academic and Research
Institutes by Geographic Region – USA, Canada, Japan, China,
Europe, Asia-Pacific, Latin America, Middle East and Africa
Markets – Independent Analysis of Annual Sales in US$ Trillion
for Years 2012 through 2017

Table 27: World 15-Year Perspective for Academic and Research
Institutes by Geographic Region – Percentage Breakdown of Value
Sales for USA, Canada, Japan, China, Europe, Asia-Pacific,
Latin America, Middle East and Africa for Years 2012, 2018 &
2027

Table 28: World Current & Future Analysis for Other End-Uses by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Trillion for Years
2018 through 2027

Table 29: World Historic Review for Other End-Uses by
Geographic Region – USA, Canada, Japan, China, Europe,
Asia-Pacific, Latin America, Middle East and Africa Markets –
Independent Analysis of Annual Sales in US$ Trillion for Years
2012 through 2017

Table 30: World 15-Year Perspective for Other End-Uses by
Geographic Region – Percentage Breakdown of Value Sales for
USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America,
Middle East and Africa for Years 2012, 2018 & 2027

III. MARKET ANALYSIS

GEOGRAPHIC MARKET ANALYSIS

UNITED STATES
Market Facts & Figures
US Microbial Fermentation Technology Market Share (in %) by
Company: 2018 & 2027
Market Analytics
Table 31: USA Current & Future Analysis for Microbial
Fermentation Technology by Product Type – Medical, Industrial,
Alcohol Beverages and Food and Feed Products – Independent
Analysis of Annual Sales in US$ Trillion for the Years 2018
through 2027

Table 32: USA Historic Review for Microbial Fermentation
Technology by Product Type – Medical, Industrial, Alcohol
Beverages and Food and Feed Products Markets – Independent
Analysis of Annual Sales in US$ Trillion for Years 2012 through
2017

Table 33: USA 15-Year Perspective for Microbial Fermentation
Technology by Product Type – Percentage Breakdown of Value
Sales for Medical, Industrial, Alcohol Beverages and Food and
Feed Products for the Years 2012, 2018 & 2027

Table 34: USA Current & Future Analysis for Microbial
Fermentation Technology by End-Use – Biopharmaceutical
Companies, Food and Feed Industry, Contract Research
Organizations (CROs) and Contract Manufacturing Organizations
(CMOs), Academic and Research Institutes and Other End-Uses –
Independent Analysis of Annual Sales in US$ Trillion for the
Years 2018 through 2027

Table 35: USA Historic Review for Microbial Fermentation
Technology by End-Use – Biopharmaceutical Companies, Food and
Feed Industry, Contract Research Organizations (CROs) and
Contract Manufacturing Organizations (CMOs), Academic and
Research Institutes and Other End-Uses Markets – Independent
Analysis of Annual Sales in US$ Trillion for Years 2012 through
2017

Table 36: USA 15-Year Perspective for Microbial Fermentation
Technology by End-Use – Percentage Breakdown of Value Sales for
Biopharmaceutical Companies, Food and Feed Industry, Contract
Research Organizations (CROs) and Contract Manufacturing
Organizations (CMOs), Academic and Research Institutes and
Other End-Uses for the Years 2012, 2018 & 2027

CANADA
Table 37: Canada Current & Future Analysis for Microbial
Fermentation Technology by Product Type – Medical, Industrial,
Alcohol Beverages and Food and Feed Products – Independent
Analysis of Annual Sales in US$ Trillion for the Years 2018
through 2027

Table 38: Canada Historic Review for Microbial Fermentation
Technology by Product Type – Medical, Industrial, Alcohol
Beverages and Food and Feed Products Markets – Independent
Analysis of Annual Sales in US$ Trillion for Years 2012 through
2017

Table 39: Canada 15-Year Perspective for Microbial Fermentation
Technology by Product Type – Percentage Breakdown of Value
Sales for Medical, Industrial, Alcohol Beverages and Food and
Feed Products for the Years 2012, 2018 & 2027

Table 40: Canada Current & Future Analysis for Microbial
Fermentation Technology by End-Use – Biopharmaceutical
Companies, Food and Feed Industry, Contract Research
Organizations (CROs) and Contract Manufacturing Organizations
(CMOs), Academic and Research Institutes and Other End-Uses –
Independent Analysis of Annual Sales in US$ Trillion for the
Years 2018 through 2027

Table 41: Canada Historic Review for Microbial Fermentation
Technology by End-Use – Biopharmaceutical Companies, Food and
Feed Industry, Contract Research Organizations (CROs) and
Contract Manufacturing Organizations (CMOs), Academic and
Research Institutes and Other End-Uses Markets – Independent
Analysis of Annual Sales in US$ Trillion for Years 2012 through
2017

Table 42: Canada 15-Year Perspective for Microbial Fermentation
Technology by End-Use – Percentage Breakdown of Value Sales for
Biopharmaceutical Companies, Food and Feed Industry, Contract
Research Organizations (CROs) and Contract Manufacturing
Organizations (CMOs), Academic and Research Institutes and
Other End-Uses for the Years 2012, 2018 & 2027

JAPAN
Table 43: Japan Current & Future Analysis for Microbial
Fermentation Technology by Product Type – Medical, Industrial,
Alcohol Beverages and Food and Feed Products – Independent
Analysis of Annual Sales in US$ Trillion for the Years 2018
through 2027

Table 44: Japan Historic Review for Microbial Fermentation
Technology by Product Type – Medical, Industrial, Alcohol
Beverages and Food and Feed Products Markets – Independent
Analysis of Annual Sales in US$ Trillion for Years 2012 through
2017

Table 45: Japan 15-Year Perspective for Microbial Fermentation
Technology by Product Type – Percentage Breakdown of Value
Sales for Medical, Industrial, Alcohol Beverages and Food and
Feed Products for the Years 2012, 2018 & 2027

Table 46: Japan Current & Future Analysis for Microbial
Fermentation Technology by End-Use – Biopharmaceutical
Companies, Food and Feed Industry, Contract Research
Organizations (CROs) and Contract Manufacturing Organizations
(CMOs), Academic and Research Institutes and Other End-Uses –
Independent Analysis of Annual Sales in US$ Trillion for the
Years 2018 through 2027

Table 47: Japan Historic Review for Microbial Fermentation
Technology by End-Use – Biopharmaceutical Companies, Food and
Feed Industry, Contract Research Organizations (CROs) and
Contract Manufacturing Organizations (CMOs), Academic and
Research Institutes and Other End-Uses Markets – Independent
Analysis of Annual Sales in US$ Trillion for Years 2012 through
2017

Table 48: Japan 15-Year Perspective for Microbial Fermentation
Technology by End-Use – Percentage Breakdown of Value Sales for
Biopharmaceutical Companies, Food and Feed Industry, Contract
Research Organizations (CROs) and Contract Manufacturing
Organizations (CMOs), Academic and Research Institutes and
Other End-Uses for the Years 2012, 2018 & 2027

CHINA
Table 49: China Current & Future Analysis for Microbial
Fermentation Technology by Product Type – Medical, Industrial,
Alcohol Beverages and Food and Feed Products – Independent
Analysis of Annual Sales in US$ Trillion for the Years 2018
through 2027

Table 50: China Historic Review for Microbial Fermentation
Technology by Product Type – Medical, Industrial, Alcohol
Beverages and Food and Feed Products Markets – Independent
Analysis of Annual Sales in US$ Trillion for Years 2012 through
2017

Table 51: China 15-Year Perspective for Microbial Fermentation
Technology by Product Type – Percentage Breakdown of Value
Sales for Medical, Industrial, Alcohol Beverages and Food and
Feed Products for the Years 2012, 2018 & 2027

Table 52: China Current & Future Analysis for Microbial
Fermentation Technology by End-Use – Biopharmaceutical
Companies, Food and Feed Industry, Contract Research
Organizations (CROs) and Contract Manufacturing Organizations
(CMOs), Academic and Research Institutes and Other End-Uses –
Independent Analysis of Annual Sales in US$ Trillion for the
Years 2018 through 2027

Table 53: China Historic Review for Microbial Fermentation
Technology by End-Use – Biopharmaceutical Companies, Food and
Feed Industry, Contract Research Organizations (CROs) and
Contract Manufacturing Organizations (CMOs), Academic and
Research Institutes and Other End-Uses Markets – Independent
Analysis of Annual Sales in US$ Trillion for Years 2012 through
2017

Table 54: China 15-Year Perspective for Microbial Fermentation
Technology by End-Use – Percentage Breakdown of Value Sales for
Biopharmaceutical Companies, Food and Feed Industry, Contract
Research Organizations (CROs) and Contract Manufacturing
Organizations (CMOs), Academic and Research Institutes and
Other End-Uses for the Years 2012, 2018 & 2027

EUROPE
Market Facts & Figures
European Microbial Fermentation Technology Market: Competitor
Market Share Scenario (in %) for 2018 & 2027
Market Analytics
Table 55: Europe Current & Future Analysis for Microbial
Fermentation Technology by Geographic Region – France, Germany,
Italy, UK, Spain, Russia and Rest of Europe Markets –
Independent Analysis of Annual Sales in US$ Trillion for Years
2018 through 2027

Table 56: Europe Historic Review for Microbial Fermentation
Technology by Geographic Region – France, Germany, Italy, UK,
Spain, Russia and Rest of Europe Markets – Independent Analysis
of Annual Sales in US$ Trillion for Years 2012 through 2017

Table 57: Europe 15-Year Perspective for Microbial Fermentation
Technology by Geographic Region – Percentage Breakdown of Value
Sales for France, Germany, Italy, UK, Spain, Russia and Rest of
Europe Markets for Years 2012, 2018 & 2027

Table 58: Europe Current & Future Analysis for Microbial
Fermentation Technology by Product Type – Medical, Industrial,
Alcohol Beverages and Food and Feed Products – Independent
Analysis of Annual Sales in US$ Trillion for the Years 2018
through 2027

Table 59: Europe Historic Review for Microbial Fermentation
Technology by Product Type – Medical, Industrial, Alcohol
Beverages and Food and Feed Products Markets – Independent
Analysis of Annual Sales in US$ Trillion for Years 2012 through
2017

Table 60: Europe 15-Year Perspective for Microbial Fermentation
Technology by Product Type – Percentage Breakdown of Value
Sales for Medical, Industrial, Alcohol Beverages and Food and
Feed Products for the Years 2012, 2018 & 2027

Table 61: Europe Current & Future Analysis for Microbial
Fermentation Technology by End-Use – Biopharmaceutical
Companies, Food and Feed Industry, Contract Research
Organizations (CROs) and Contract Manufacturing Organizations
(CMOs), Academic and Research Institutes and Other End-Uses –
Independent Analysis of Annual Sales in US$ Trillion for the
Years 2018 through 2027

Table 62: Europe Historic Review for Microbial Fermentation
Technology by End-Use – Biopharmaceutical Companies, Food and
Feed Industry, Contract Research Organizations (CROs) and
Contract Manufacturing Organizations (CMOs), Academic and
Research Institutes and Other End-Uses Markets – Independent
Analysis of Annual Sales in US$ Trillion for Years 2012 through
2017

Table 63: Europe 15-Year Perspective for Microbial Fermentation
Technology by End-Use – Percentage Breakdown of Value Sales for
Biopharmaceutical Companies, Food and Feed Industry, Contract
Research Organizations (CROs) and Contract Manufacturing
Organizations (CMOs), Academic and Research Institutes and
Other End-Uses for the Years 2012, 2018 & 2027

FRANCE
Table 64: France Current & Future Analysis for Microbial
Fermentation Technology by Product Type – Medical, Industrial,
Alcohol Beverages and Food and Feed Products – Independent
Analysis of Annual Sales in US$ Trillion for the Years 2018
through 2027

Table 65: France Historic Review for Microbial Fermentation
Technology by Product Type – Medical, Industrial, Alcohol
Beverages and Food and Feed Products Markets – Independent
Analysis of Annual Sales in US$ Trillion for Years 2012 through
2017

Table 66: France 15-Year Perspective for Microbial Fermentation
Technology by Product Type – Percentage Breakdown of Value
Sales for Medical, Industrial, Alcohol Beverages and Food and
Feed Products for the Years 2012, 2018 & 2027

Table 67: France Current & Future Analysis for Microbial
Fermentation Technology by End-Use – Biopharmaceutical
Companies, Food and Feed Industry, Contract Research
Organizations (CROs) and Contract Manufacturing Organizations
(CMOs), Academic and Research Institutes and Other End-Uses –
Independent Analysis of Annual Sales in US$ Trillion for the
Years 2018 through 2027

Table 68: France Historic Review for Microbial Fermentation
Technology by End-Use – Biopharmaceutical Companies, Food and
Feed Industry, Contract Research Organizations (CROs) and
Contract Manufacturing Organizations (CMOs), Academic and
Research Institutes and Other End-Uses Markets – Independent
Analysis of Annual Sales in US$ Trillion for Years 2012 through
2017

Table 69: France 15-Year Perspective for Microbial Fermentation
Technology by End-Use – Percentage Breakdown of Value Sales for
Biopharmaceutical Companies, Food and Feed Industry, Contract
Research Organizations (CROs) and Contract Manufacturing
Organizations (CMOs), Academic and Research Institutes and
Other End-Uses for the Years 2012, 2018 & 2027

GERMANY
Table 70: Germany Current & Future Analysis for Microbial
Fermentation Technology by Product Type – Medical, Industrial,
Alcohol Beverages and Food and Feed Products – Independent
Analysis of Annual Sales in US$ Trillion for the Years 2018
through 2027

Table 71: Germany Historic Review for Microbial Fermentation
Technology by Product Type – Medical, Industrial, Alcohol
Beverages and Food and Feed Products Markets – Independent
Analysis of Annual Sales in US$ Trillion for Years 2012 through
2017

Table 72: Germany 15-Year Perspective for Microbial
Fermentation Technology by Product Type – Percentage Breakdown
of Value Sales for Medical, Industrial, Alcohol Beverages and
Food and Feed Products for the Years 2012, 2018 & 2027

Table 73: Germany Current & Future Analysis for Microbial
Fermentation Technology by End-Use – Biopharmaceutical
Companies, Food and Feed Industry, Contract Research
Organizations (CROs) and Contract Manufacturing Organizations
(CMOs), Academic and Research Institutes and Other End-Uses –
Independent Analysis of Annual Sales in US$ Trillion for the
Years 2018 through 2027

Table 74: Germany Historic Review for Microbial Fermentation
Technology by End-Use – Biopharmaceutical Companies, Food and
Feed Industry, Contract Research Organizations (CROs) and
Contract Manufacturing Organizations (CMOs), Academic and
Research Institutes and Other End-Uses Markets – Independent
Analysis of Annual Sales in US$ Trillion for Years 2012 through
2017

Table 75: Germany 15-Year Perspective for Microbial
Fermentation Technology by End-Use – Percentage Breakdown of
Value Sales for Biopharmaceutical Companies, Food and Feed
Industry, Contract Research Organizations (CROs) and Contract
Manufacturing Organizations (CMOs), Academic and Research
Institutes and Other End-Uses for the Years 2012, 2018 & 2027

ITALY
Table 76: Italy Current & Future Analysis for Microbial
Fermentation Technology by Product Type – Medical, Industrial,
Alcohol Beverages and Food and Feed Products – Independent
Analysis of Annual Sales in US$ Trillion for the Years 2018
through 2027

Table 77: Italy Historic Review for Microbial Fermentation
Technology by Product Type – Medical, Industrial, Alcohol
Beverages and Food and Feed Products Markets – Independent
Analysis of Annual Sales in US$ Trillion for Years 2012 through
2017

Table 78: Italy 15-Year Perspective for Microbial Fermentation
Technology by Product Type – Percentage Breakdown of Value
Sales for Medical, Industrial, Alcohol Beverages and Food and
Feed Products for the Years 2012, 2018 & 2027

Table 79: Italy Current & Future Analysis for Microbial
Fermentation Technology by End-Use – Biopharmaceutical
Companies, Food and Feed Industry, Contract Research
Organizations (CROs) and Contract Manufacturing Organizations
(CMOs), Academic and Research Institutes and Other End-Uses –
Independent Analysis of Annual Sales in US$ Trillion for the
Years 2018 through 2027

Table 80: Italy Historic Review for Microbial Fermentation
Technology by End-Use – Biopharmaceutical Companies, Food and
Feed Industry, Contract Research Organizations (CROs) and
Contract Manufacturing Organizations (CMOs), Academic and
Research Institutes and Other End-Uses Markets – Independent
Analysis of Annual Sales in US$ Trillion for Years 2012 through
2017

Table 81: Italy 15-Year Perspective for Microbial Fermentation
Technology by End-Use – Percentage Breakdown of Value Sales for
Biopharmaceutical Companies, Food and Feed Industry, Contract
Research Organizations (CROs) and Contract Manufacturing
Organizations (CMOs), Academic and Research Institutes and
Other End-Uses for the Years 2012, 2018 & 2027

UNITED KINGDOM
Table 82: UK Current & Future Analysis for Microbial
Fermentation Technology by Product Type – Medical, Industrial,
Alcohol Beverages and Food and Feed Products – Independent
Analysis of Annual Sales in US$ Trillion for the Years 2018
through 2027

Table 83: UK Historic Review for Microbial Fermentation
Technology by Product Type – Medical, Industrial, Alcohol
Beverages and Food and Feed Products Markets – Independent
Analysis of Annual Sales in US$ Trillion for Years 2012 through
2017

Table 84: UK 15-Year Perspective for Microbial Fermentation
Technology by Product Type – Percentage Breakdown of Value
Sales for Medical, Industrial, Alcohol Beverages and Food and
Feed Products for the Years 2012, 2018 & 2027

Table 85: UK Current & Future Analysis for Microbial
Fermentation Technology by End-Use – Biopharmaceutical
Companies, Food and Feed Industry, Contract Research
Organizations (CROs) and Contract Manufacturing Organizations
(CMOs), Academic and Research Institutes and Other End-Uses –
Independent Analysis of Annual Sales in US$ Trillion for the
Years 2018 through 2027

Table 86: UK Historic Review for Microbial Fermentation
Technology by End-Use – Biopharmaceutical Companies, Food and
Feed Industry, Contract Research Organizations (CROs) and
Contract Manufacturing Organizations (CMOs), Academic and
Research Institutes and Other End-Uses Markets – Independent
Analysis of Annual Sales in US$ Trillion for Years 2012 through
2017

Table 87: UK 15-Year Perspective for Microbial Fermentation
Technology by End-Use – Percentage Breakdown of Value Sales for
Biopharmaceutical Companies, Food and Feed Industry, Contract
Research Organizations (CROs) and Contract Manufacturing
Organizations (CMOs), Academic and Research Institutes and
Other End-Uses for the Years 2012, 2018 & 2027

SPAIN
Table 88: Spain Current & Future Analysis for Microbial
Fermentation Technology by Product Type – Medical, Industrial,
Alcohol Beverages and Food and Feed Products – Independent
Analysis of Annual Sales in US$ Trillion for the Years 2018
through 2027

Table 89: Spain Historic Review for Microbial Fermentation
Technology by Product Type – Medical, Industrial, Alcohol
Beverages and Food and Feed Products Markets – Independent
Analysis of Annual Sales in US$ Trillion for Years 2012 through
2017

Table 90: Spain 15-Year Perspective for Microbial Fermentation
Technology by Product Type – Percentage Breakdown of Value
Sales for Medical, Industrial, Alcohol Beverages and Food and
Feed Products for the Years 2012, 2018 & 2027

Table 91: Spain Current & Future Analysis for Microbial
Fermentation Technology by End-Use – Biopharmaceutical
Companies, Food and Feed Industry, Contract Research
Organizations (CROs) and Contract Manufacturing Organizations
(CMOs), Academic and Research Institutes and Other End-Uses –
Independent Analysis of Annual Sales in US$ Trillion for the
Years 2018 through 2027

Table 92: Spain Historic Review for Microbial Fermentation
Technology by End-Use – Biopharmaceutical Companies, Food and
Feed Industry, Contract Research Organizations (CROs) and
Contract Manufacturing Organizations (CMOs), Academic and
Research Institutes and Other End-Uses Markets – Independent
Analysis of Annual Sales in US$ Trillion for Years 2012 through
2017

Table 93: Spain 15-Year Perspective for Microbial Fermentation
Technology by End-Use – Percentage Breakdown of Value Sales for
Biopharmaceutical Companies, Food and Feed Industry, Contract
Research Organizations (CROs) and Contract Manufacturing
Organizations (CMOs), Academic and Research Institutes and
Other End-Uses for the Years 2012, 2018 & 2027

RUSSIA
Table 94: Russia Current & Future Analysis for Microbial
Fermentation Technology by Product Type – Medical, Industrial,
Alcohol Beverages and Food and Feed Products – Independent
Analysis of Annual Sales in US$ Trillion for the Years 2018
through 2027

Table 95: Russia Historic Review for Microbial Fermentation
Technology by Product Type – Medical, Industrial, Alcohol
Beverages and Food and Feed Products Markets – Independent
Analysis of Annual Sales in US$ Trillion for Years 2012 through
2017

Table 96: Russia 15-Year Perspective for Microbial Fermentation
Technology by Product Type – Percentage Breakdown of Value
Sales for Medical, Industrial, Alcohol Beverages and Food and
Feed Products for the Years 2012, 2018 & 2027

Table 97: Russia Current & Future Analysis for Microbial
Fermentation Technology by End-Use – Biopharmaceutical
Companies, Food and Feed Industry, Contract Research
Organizations (CROs) and Contract Manufacturing Organizations
(CMOs), Academic and Research Institutes and Other End-Uses –
Independent Analysis of Annual Sales in US$ Trillion for the
Years 2018 through 2027

Table 98: Russia Historic Review for Microbial Fermentation
Technology by End-Use – Biopharmaceutical Companies, Food and
Feed Industry, Contract Research Organizations (CROs) and
Contract Manufacturing Organizations (CMOs), Academic and
Research Institutes and Other End-Uses Markets – Independent
Analysis of Annual Sales in US$ Trillion for Years 2012 through
2017

Table 99: Russia 15-Year Perspective for Microbial Fermentation
Technology by End-Use – Percentage Breakdown of Value Sales for
Biopharmaceutical Companies, Food and Feed Industry, Contract
Research Organizations (CROs) and Contract Manufacturing
Organizations (CMOs), Academic and Research Institutes and
Other End-Uses for the Years 2012, 2018 & 2027

REST OF EUROPE
Table 100: Rest of Europe Current & Future Analysis for
Microbial Fermentation Technology by Product Type – Medical,
Industrial, Alcohol Beverages and Food and Feed Products –
Independent Analysis of Annual Sales in US$ Trillion for the
Years 2018 through 2027

Table 101: Rest of Europe Historic Review for Microbial
Fermentation Technology by Product Type – Medical, Industrial,
Alcohol Beverages and Food and Feed Products Markets –
Independent Analysis of Annual Sales in US$ Trillion for Years
2012 through 2017

Table 102: Rest of Europe 15-Year Perspective for Microbial
Fermentation Technology by Product Type – Percentage Breakdown
of Value Sales for Medical, Industrial, Alcohol Beverages and
Food and Feed Products for the Years 2012, 2018 & 2027

Table 103: Rest of Europe Current & Future Analysis for
Microbial Fermentation Technology by End-Use –
Biopharmaceutical Companies, Food and Feed Industry, Contract
Research Organizations (CROs) and Contract Manufacturing
Organizations (CMOs), Academic and Research Institutes and
Other End-Uses – Independent Analysis of Annual Sales in US$
Trillion for the Years 2018 through 2027

Table 104: Rest of Europe Historic Review for Microbial
Fermentation Technology by End-Use – Biopharmaceutical
Companies, Food and Feed Industry, Contract Research
Organizations (CROs) and Contract Manufacturing Organizations
(CMOs), Academic and Research Institutes and Other End-Uses
Markets – Independent Analysis of Annual Sales in US$ Trillion
for Years 2012 through 2017

Table 105: Rest of Europe 15-Year Perspective for Microbial
Fermentation Technology by End-Use – Percentage Breakdown of
Value Sales for Biopharmaceutical Companies, Food and Feed
Industry, Contract Research Organizations (CROs) and Contract
Manufacturing Organizations (CMOs), Academic and Research
Institutes and Other End-Uses for the Years 2012, 2018 & 2027

ASIA-PACIFIC
Table 106: Asia-Pacific Current & Future Analysis for Microbial
Fermentation Technology by Geographic Region – Australia,
India, South Korea and Rest of Asia-Pacific Markets –
Independent Analysis of Annual Sales in US$ Trillion for Years
2018 through 2027

Please contact our Customer Support Center to get the complete Table of Contents
Read the full report: https://www.reportlinker.com/p05961041/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need – instantly, in one place.

__________________________

Clare: [email protected]
US: (339)-368-6001
Intl: +1 339-368-6001